Session Details

F126 Combatting misinformation and positioning the specialty on social media

Sat, Mar 9, 1:00 PM - 3:00 PM
Room 6B
2 CME Available Forum Practice Management
View Map

DESCRIPTION

Social media is a great professional tool that can be used to educate the public, positively position the specialty, and enhance your career. Yet, staying current in today’s fast-paced social media world can be time-consuming. This course will provide attendees with tips and strategies for building and maintaining a reliable and reputable presence on social media. Discover how to develop educational and engaging content that delivers a consistent message about the specialty and its expertise. Receive guidance on how to manage negative comments and learn the dos and don’ts of social media.

LEARNING OBJECTIVES

1.

Develop a strategy to use social media as a professional tool

2.

Create engaging content that educates the public and positively positions the specialty

3.

Recognize standards of professionalism and respond appropriately to negative comments

DIRECTOR

Ronda S. Farah, MD, FAAD

Ronda S. Farah, MD, FAAD

SPEAKERS

Kara Jilek

Kara Jilek

Sara Moghaddam, MD, FAAD

Sara Moghaddam, MD, FAAD

Oyetewa Oyerinde, MD, FAAD

Oyetewa Oyerinde, MD, FAAD

HANDOUTS

Login to view handouts

DISCLOSURES

Ronda S. Farah, MD, FAAD

American Academy of Dermatology – Other(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); ASLAN Pharmaceuticals – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Early Sullivan Wright Gizer & McRae LLP – Consultant (1099 relationship)(Fees); Eli Lilly – Investigator(Grants/Research Funding); Novartis – Advisory Board(Fees); Pfizer – Investigator(Grants/Research Funding); Pfizer Inc. – Stockholder(No Compensation Received), Stockholder Public Company(No Compensation Received); Technoderma Medicines – Investigator(Grants/Research Funding);

Kara Jilek

No financial relationships exist with ineligible companies.

Sara Moghaddam, MD, FAAD

No financial relationships exist with ineligible companies.

Oyetewa Oyerinde, MD, FAAD

No financial relationships exist with ineligible companies.